In the first four months of 2026, OpenAI has rolled out a series of healthcare-focused products and announcements, including a consumer health feature, a suite of hospital tools, a clinician-facing offering, a biology research model and an acquisition of a health data startup.
OpenAI’s healthcare push comes as some of the largest technology companies in the world are racing to establish positions in the sector. Microsoft, OpenAI, Amazon and others have been expanding their medical AI offerings. OpenAI’s series of launches this year places it squarely in the middle of that competition.
Here is a look at OpenAI’s biggest healthcare moves, as reported by Becker’s since January:
Editor’s note: This article was updated June 18 and will continue to be updated with the latest news.
January
- OpenAI rolled out ChatGPT Health, a new feature that allows users to securely integrate personal health information with ChatGPT’s AI to better understand and manage health-related questions.
- OpenAI-led research released in January found that more than 40 million Americans use ChatGPT daily to ask questions about healthcare.
- OpenAI launched OpenAI for Healthcare, a suite of AI products aimed at supporting clinical and administrative work at hospitals and health systems. The launch included ChatGPT for Healthcare and the OpenAI API for Healthcare.
- The company also announced that it would be acquiring Torch, a healthcare startup focused on unifying lab results, medication data and visit recordings.
April
- OpenAI introduced a new advanced AI model, GPT-Rosalind, to support research into biology, drug discovery and translational medicine.
- OpenAI launched ChatGPT for Clinicians, a new tool designed to support healthcare professionals with tasks such as clinical documentation, drafting written materials and conducting medical research. The offering is available at no cost to verified U.S.-based physicians, nurse practitioners, physician assistants and pharmacists.
- OpenAI released a report, “Keeping Patients First: A Blueprint for AI in U.S. Healthcare,” calling for broader patient access to medical data, expanded clinician use of AI tools and updated regulatory pathways for AI-supported care.
May
- OpenAI released a healthcare policy blueprint that called for expanded patient access to health data, greater use of clinician-supervised AI tools and updated regulations to support AI adoption in care delivery. The report argued that AI can reduce administrative burdens and improve access to care while emphasizing that clinicians, not AI, should remain responsible for medical decisions.
June
- Boston Children’s Hospital reported that its enterprise partnership with OpenAI has helped reclaim about 60,000 work hours and save more than $7 million through AI-enabled workflows. The health system also has used AI to help diagnose more than 40 previously unresolved rare conditions and support operations ranging from supply chain management to physician decision support, with more than one-third of employees using AI daily.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.